BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Alibaba
BABA
|
+$1.45B |
| 2 |
Visa
V
|
+$458M |
| 3 |
Technology Select Sector SPDR Fund
XLK
|
+$431M |
| 4 |
DuPont de Nemours
DD
|
+$308M |
| 5 |
NVIDIA
NVDA
|
+$299M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$705M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$430M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$257M |
| 4 |
Industrial Select Sector SPDR Fund
XLI
|
+$256M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$243M |
Sector Composition
| 1 | Technology | 22.57% |
| 2 | Consumer Discretionary | 13.95% |
| 3 | Healthcare | 10.5% |
| 4 | Financials | 8.72% |
| 5 | Industrials | 6.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PDCO
1151
DELISTED
Patterson Companies, Inc.
PDCO
| $2.26M | ﹤0.01% |
67,907
+27,315
| +67% | +$908K |
|
1152
Collegium Pharmaceutical
COLL
$1.18B
| $2.26M | ﹤0.01% |
105,045
-41,148
| -28% | -$884K |
|
|
BPMC
1153
DELISTED
Blueprint Medicines
BPMC
| $2.24M | ﹤0.01% |
35,512
-32,756
| -48% | -$2.07M |
|
1154
Chart Industries
GTLS
$8.95B
| $2.24M | ﹤0.01% |
14,007
-43,213
| -76% | -$6.91M |
|
1155
Saic
SAIC
$4.9B
| $2.23M | ﹤0.01% |
19,869
+5,761
| +41% | +$648K |
|
1156
Sterling Infrastructure
STRL
$9.54B
| $2.23M | ﹤0.01% |
39,966
+3,315
| +9% | +$185K |
|
1157
Wabash National
WNC
$457M
| $2.23M | ﹤0.01% |
86,881
+16,389
| +23% | +$420K |
|
1158
Cognex
CGNX
$7.45B
| $2.22M | ﹤0.01% |
39,658
-69,834
| -64% | -$3.91M |
|
1159
Credit Acceptance
CACC
$5.33B
| $2.22M | ﹤0.01% |
4,371
+13
| +0.3% | +$6.6K |
|
1160
Americold
COLD
$3.93B
| $2.22M | ﹤0.01% |
68,585
+942
| +1% | +$30.4K |
|
1161
Macy's
M
$4.54B
| $2.21M | ﹤0.01% |
137,877
-24,673
| -15% | -$396K |
|
1162
SLM Corp
SLM
$5.86B
| $2.21M | ﹤0.01% |
135,368
+121,615
| +884% | +$1.98M |
|
|
SAGE
1163
DELISTED
Sage Therapeutics
SAGE
| $2.21M | ﹤0.01% |
46,972
-24,704
| -34% | -$1.16M |
|
1164
National Health Investors
NHI
$3.72B
| $2.21M | ﹤0.01% |
42,101
+435
| +1% | +$22.8K |
|
1165
Ares Management
ARES
$40.1B
| $2.21M | ﹤0.01% |
22,887
-1,033
| -4% | -$99.5K |
|
1166
New Jersey Resources
NJR
$4.74B
| $2.2M | ﹤0.01% |
46,505
-30,115
| -39% | -$1.42M |
|
1167
Tilray
TLRY
$1.25B
| $2.19M | ﹤0.01% |
1,404,177
+496,418
| +55% | +$774K |
|
1168
Wingstop
WING
$7.43B
| $2.19M | ﹤0.01% |
10,930
-8,522
| -44% | -$1.71M |
|
1169
Metropolitan Bank Holding Corp
MCB
$807M
| $2.19M | ﹤0.01% |
62,980
+43,002
| +215% | +$1.49M |
|
1170
Visteon
VC
$3.4B
| $2.17M | ﹤0.01% |
15,127
-6,758
| -31% | -$971K |
|
1171
AeroVironment
AVAV
$12.1B
| $2.17M | ﹤0.01% |
21,236
-3,189
| -13% | -$326K |
|
|
VGR
1172
DELISTED
Vector Group Ltd.
VGR
| $2.17M | ﹤0.01% |
169,114
+16,292
| +11% | +$209K |
|
1173
PotlatchDeltic
PCH
$3.2B
| $2.16M | ﹤0.01% |
40,911
-14,916
| -27% | -$788K |
|
1174
Advanced Energy
AEIS
$5.94B
| $2.15M | ﹤0.01% |
19,325
-9,670
| -33% | -$1.08M |
|
1175
TTM Technologies
TTMI
$4.83B
| $2.15M | ﹤0.01% |
154,619
-39,276
| -20% | -$546K |
|